Skip to main content
In stock|Cytotoxic Chemotherapy

Decitabine + Cedazuridine (Oral Fixed-Dose)

Oncology TypeHematologic (MDS/AML)
Drug Class / MechanismOral Hypomethylating Agent + Cytidine Deaminase Inhibitor
No Image
Description

Decitabine + Cedazuridine (Oral Fixed-Dose) is classified as an Oral Hypomethylating Agent + Cytidine Deaminase Inhibitor, sourced for use within our Cytotoxic Chemotherapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryCytotoxic Chemotherapy
Oncology TypeHematologic (MDS/AML)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3